Here are the latest growth forecasts for the CSL share price
Image source: Getty Images
The CSL Ltd (ASX: CSL) share price has fallen by a third over the past year, as the chart below shows. After such a difficult period for the ASX healthcare share, it’s good to look at what the company’s prospects are.
The blood plasma product and vaccine business has seen a sell-off amid lower growth prospects, including a less positive market in the US with healthcare changes by the administration.
We’re going to look at the expectations for the CSL share price. This is called the share price target, which is where analysts expect the share price to trade in 12 months from the time of the investment call.
The projections may surprise you.
Analyst views on the CSL share price
According to a CMC Markets…
